TYBOURNE CAPITAL MANAGEMENT (HK) LTD – Inhibrx Biosciences, Inc. Transaction History
TYBOURNE CAPITAL MANAGEMENT (HK) LTD portfolio value:
$11.59M
portfolio value
TYBOURNE CAPITAL MANAGEMENT (HK) LTD quarter portfolio value change:
+58.15%
quarter
Inhibrx Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -18.73% | -148.86K shares | 2.57M | $17.95 | 645.81K |
| Q2 2022 | share | 0.00% | 0 shares | -8.68M | $11.35 | 794.68K | |
| Q1 2022 | share | Decrease | -22.72% | -233.62K shares | -27.2M | $22.28 | 794.68K |
| Q4 2021 | share | 0.00% | 0 shares | 10.65M | $43.06 | 1.02M | |
| Q3 2021 | share | Decrease | -6.52% | -71.69K shares | 3.98M | $33.31 | 1.02M |
| Q2 2021 | share | 0.00% | 0 shares | 8.19M | $27.52 | 1.1M | |
| Q1 2021 | share | 0.00% | 0 shares | -14.19M | $20.07 | 1.1M | |
| Q4 2020 | share | 0.00% | 0 shares | 16.46M | $32.97 | 1.1M | |
| Q3 2020 | share | Increase | 0.00% | 1.1M shares | 19.8M | $18 | 1.1M |